Bill
H 2200
Overview: H 2200, "An Act relative to the prescription monitoring program", was introduced on February 27, 2025 and has a hearing scheduled for November 3, 2025 from 1:00 PM to 5:0
Overview: H 2200, "An Act relative to the prescription monitoring program", was introduced on February 27, 2025 and has a hearing scheduled for November 3, 2025 from 1:00 PM to 5:00 PM in room A-2.
Purpose and Intent: The main purpose of this bill is to make changes and enhancements to the state's prescription monitoring program, which tracks the prescribing and dispensing of controlled substances.
Key Provisions:
- Expands the types of healthcare providers required to report to the prescription monitoring program
- Mandates more frequent reporting of prescription data by pharmacies and other dispensers
- Enhances the program's data analysis capabilities to identify potential misuse or diversion of controlled substances
Affected Parties and Impacts: The bill will impact healthcare providers, pharmacies, and other entities that prescribe or dispense controlled substances, as they will be subject to the expanded reporting requirements. Patients may also be affected through improved monitoring and detection of potential prescription drug abuse or misuse.
Procedural and Timeline Considerations: The bill is currently scheduled for a hearing in the legislature on November 3, 2025. The outcome of this hearing will determine the next steps in the legislative process.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
